Cargando…
Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
Pin1 is the only known peptidyl-prolyl cis–trans isomerase (PPIase) that specifically recognizes and isomerizes the phosphorylated Serine/Threonine-Proline (pSer/Thr-Pro) motif. The Pin1-mediated structural transformation posttranslationally regulates the biofunctions of multiple proteins. Pin1 is i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115400/ https://www.ncbi.nlm.nih.gov/pubmed/30158600 http://dx.doi.org/10.1038/s41419-018-0844-y |
_version_ | 1783351375216771072 |
---|---|
author | Chen, Yang Wu, Ya-ran Yang, Hong-ying Li, Xin-zhe Jie, Meng-meng Hu, Chang-jiang Wu, Yu-yun Yang, Shi-ming Yang, Ying-bin |
author_facet | Chen, Yang Wu, Ya-ran Yang, Hong-ying Li, Xin-zhe Jie, Meng-meng Hu, Chang-jiang Wu, Yu-yun Yang, Shi-ming Yang, Ying-bin |
author_sort | Chen, Yang |
collection | PubMed |
description | Pin1 is the only known peptidyl-prolyl cis–trans isomerase (PPIase) that specifically recognizes and isomerizes the phosphorylated Serine/Threonine-Proline (pSer/Thr-Pro) motif. The Pin1-mediated structural transformation posttranslationally regulates the biofunctions of multiple proteins. Pin1 is involved in many cellular processes, the aberrance of which lead to both degenerative and neoplastic diseases. Pin1 is highly expressed in the majority of cancers and its deficiency significantly suppresses cancer progression. According to the ground-breaking summaries by Hanahan D and Weinberg RA, the hallmarks of cancer comprise ten biological capabilities. Multiple researches illuminated that Pin1 contributes to these aberrant behaviors of cancer via promoting various cancer-driving pathways. This review summarized the detailed mechanisms of Pin1 in different cancer capabilities and certain Pin1-targeted small-molecule compounds that exhibit anticancer activities, expecting to facilitate anticancer therapies by targeting Pin1. |
format | Online Article Text |
id | pubmed-6115400 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61154002018-08-30 Prolyl isomerase Pin1: a promoter of cancer and a target for therapy Chen, Yang Wu, Ya-ran Yang, Hong-ying Li, Xin-zhe Jie, Meng-meng Hu, Chang-jiang Wu, Yu-yun Yang, Shi-ming Yang, Ying-bin Cell Death Dis Review Article Pin1 is the only known peptidyl-prolyl cis–trans isomerase (PPIase) that specifically recognizes and isomerizes the phosphorylated Serine/Threonine-Proline (pSer/Thr-Pro) motif. The Pin1-mediated structural transformation posttranslationally regulates the biofunctions of multiple proteins. Pin1 is involved in many cellular processes, the aberrance of which lead to both degenerative and neoplastic diseases. Pin1 is highly expressed in the majority of cancers and its deficiency significantly suppresses cancer progression. According to the ground-breaking summaries by Hanahan D and Weinberg RA, the hallmarks of cancer comprise ten biological capabilities. Multiple researches illuminated that Pin1 contributes to these aberrant behaviors of cancer via promoting various cancer-driving pathways. This review summarized the detailed mechanisms of Pin1 in different cancer capabilities and certain Pin1-targeted small-molecule compounds that exhibit anticancer activities, expecting to facilitate anticancer therapies by targeting Pin1. Nature Publishing Group UK 2018-08-29 /pmc/articles/PMC6115400/ /pubmed/30158600 http://dx.doi.org/10.1038/s41419-018-0844-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Chen, Yang Wu, Ya-ran Yang, Hong-ying Li, Xin-zhe Jie, Meng-meng Hu, Chang-jiang Wu, Yu-yun Yang, Shi-ming Yang, Ying-bin Prolyl isomerase Pin1: a promoter of cancer and a target for therapy |
title | Prolyl isomerase Pin1: a promoter of cancer and a target for therapy |
title_full | Prolyl isomerase Pin1: a promoter of cancer and a target for therapy |
title_fullStr | Prolyl isomerase Pin1: a promoter of cancer and a target for therapy |
title_full_unstemmed | Prolyl isomerase Pin1: a promoter of cancer and a target for therapy |
title_short | Prolyl isomerase Pin1: a promoter of cancer and a target for therapy |
title_sort | prolyl isomerase pin1: a promoter of cancer and a target for therapy |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115400/ https://www.ncbi.nlm.nih.gov/pubmed/30158600 http://dx.doi.org/10.1038/s41419-018-0844-y |
work_keys_str_mv | AT chenyang prolylisomerasepin1apromoterofcancerandatargetfortherapy AT wuyaran prolylisomerasepin1apromoterofcancerandatargetfortherapy AT yanghongying prolylisomerasepin1apromoterofcancerandatargetfortherapy AT lixinzhe prolylisomerasepin1apromoterofcancerandatargetfortherapy AT jiemengmeng prolylisomerasepin1apromoterofcancerandatargetfortherapy AT huchangjiang prolylisomerasepin1apromoterofcancerandatargetfortherapy AT wuyuyun prolylisomerasepin1apromoterofcancerandatargetfortherapy AT yangshiming prolylisomerasepin1apromoterofcancerandatargetfortherapy AT yangyingbin prolylisomerasepin1apromoterofcancerandatargetfortherapy |